Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Rxo (RXO) Assets Average (2022 - 2025)

Historic Assets Average for Rxo (RXO) over the last 4 years, with Q4 2025 value amounting to $3.2 billion.

  • Rxo's Assets Average fell 481.93% to $3.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.2 billion, marking a year-over-year decrease of 481.93%. This contributed to the annual value of $3.3 billion for FY2025, which is 2771.52% up from last year.
  • Rxo's Assets Average amounted to $3.2 billion in Q4 2025, which was down 481.93% from $3.2 billion recorded in Q3 2025.
  • In the past 5 years, Rxo's Assets Average registered a high of $3.4 billion during Q4 2024, and its lowest value of $1.8 billion during Q2 2024.
  • Its 4-year average for Assets Average is $2.5 billion, with a median of $2.1 billion in 2022.
  • In the last 5 years, Rxo's Assets Average tumbled by 1164.48% in 2023 and then soared by 8537.53% in 2025.
  • Quarter analysis of 4 years shows Rxo's Assets Average stood at $2.1 billion in 2022, then decreased by 11.64% to $1.9 billion in 2023, then surged by 80.48% to $3.4 billion in 2024, then dropped by 4.82% to $3.2 billion in 2025.
  • Its Assets Average was $3.2 billion in Q4 2025, compared to $3.2 billion in Q3 2025 and $3.3 billion in Q2 2025.